4.N16:95-2-22

ABUSE OF DANGEROUS LICIT AND ILLICIT DRUGS. PSYCHOTROPICS, PHENCYCLIDINE (PCP), AND TALWIN,

95-2

HEARINGS

BEFORE THE

SELECT COMMITTEE ON
NARCOTICS ABUSE AND CONTROL

HOUSE OF REPRESENTATIVES

NINETY-FIFTH CONGRESS

SECOND SESSION

AUGUST 8, 10, SEPTEMBER 19, AND OCTOBER 6, 1978

Printed for the use of the

Select Committee on Narcotics Abuse and Control

38-999 O

ABUSE OF DANGEROUS LICIT AND ILLICIT DRUGS-
PSYCHOTROPICS, PHENCYCLIDINE (PCP), AND TALWIN

HEARINGS

BEFORE THE

SELECT COMMITTEE ON
NARCOTICS ABUSE AND CONTROL

HOUSE OF REPRESENTATIVES

NINETY-FIFTH CONGRESS

SECOND SESSION

AUGUST 8, 10, SEPTEMBER 19, AND OCTOBER 6, 1978

CONTENTS

Tuesday, August 8, 1978_.

Testimony of Hon. Norman Y. Mineta, a Representative in Congress

from the State of California_.

Testimony of Lee I. Dogoloff, Associate Director, Domestic Policy

Staff, the White House..

Testimony of Peter B. Bensinger, Administrator, Drug Enforcement

Administration; accompanied by James M. Smith, Special Agent,

Los Angeles Regional Office, DEA

Testimony of Dorynne Czechowicz, M.D., Special Assistant to the

Director of the Division of Community Assistance, and Chairman

of the National Institute on Drug Abuse PCP Task Force; accom-

panied by Dr. Robert C. Petersen, NIDA.

Afternoon session, August 8, 1978__

Testimony of Hon. Lloyd Bentsen, a Senator from the State of Texas.

Testimony of Iola Scrafford, director, crossroads program, Fairfax, Va.;

accompanied by Edward Rugenstein and Steve Rugenstein__

Testimony of Paul Luisada, M.D., psychiatrist and Deputy Medical

Director of the Area D Community Mental Health Center, National

Institute of Mental Health_ _

Testimony of Frank E. Minyard, M.D., coroner of Orleans Parish,

New Orleans, La

Testimony of Lt. James Elkins, director of vice/narcotics division,

Montgomery County, Md., Department of Police-

Submissions for the record:

Letter to Chairman Wolff from Lee I. Dogoloff, dated October 13,

1978___

79

Letter to Chairman Wolff from William S. Apple, American

Pharmaceutical Association_

83

Letter to Chairman Wolff from Lee I. Dogoloff, dated October 17,

1978__

84

Thursday, August 10, 1978.

Testimony of Charles Brannan, former detailman with Hoffmann-

La Roche Inc..

119

121

Testimony of Dr. Leonard G. Schifrin, professor of economics, Col-

lege of William and Mary, Williamsburg, Va-----

149

Testimony of Jonathan O. Cole, M.D., psychopharmacology program,

McLean Hospital, Belmont, Mass.

Afternoon session, August 10, 1978_

151

167

Testimony of Irwin Lerner, vice president of marketing, Hoffmann-

La Roche Inc..

168

Testimony of Ms. Sue Boe, assistant vice president, consumer affairs

of the Pharmaceutical Manufacturers Association; accompanied by

Bruce J. Brennan, vice president and general counsel..

Testimony of Robert F. Maronde, M.D., professor of medicine,

section of chemical pharmacology, University of

California.

195

199